These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21085663)

  • 1. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
    Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
    Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation.
    Ștefănescu R; Lupu L; Manea M; Iacob RE; Przybylski M
    J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29322650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Canovi M; Markoutsa E; Lazar AN; Pampalakis G; Clemente C; Re F; Sesana S; Masserini M; Salmona M; Duyckaerts C; Flores O; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Aug; 32(23):5489-97. PubMed ID: 21529932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
    J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects.
    Klaver AC; Coffey MP; Smith LM; Bennett DA; Finke JM; Dang L; Loeffler DA
    J Neuroinflammation; 2011 Aug; 8():93. PubMed ID: 21827691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
    Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
    FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generic method for design of oligomer-specific antibodies.
    Brännström K; Lindhagen-Persson M; Gharibyan AL; Iakovleva I; Vestling M; Sellin ME; Brännström T; Morozova-Roche L; Forsgren L; Olofsson A
    PLoS One; 2014; 9(3):e90857. PubMed ID: 24618582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial.
    Davtyan H; Ghochikyan A; Petrushina I; Hovakimyan A; Davtyan A; Poghosyan A; Marleau AM; Movsesyan N; Kiyatkin A; Rasool S; Larsen AK; Madsen PJ; Wegener KM; Ditlevsen DK; Cribbs DH; Pedersen LO; Agadjanyan MG
    J Neurosci; 2013 Mar; 33(11):4923-34. PubMed ID: 23486963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia.
    Morkuniene R; Zvirbliene A; Dalgediene I; Cizas P; Jankeviciute S; Baliutyte G; Jokubka R; Jankunec M; Valincius G; Borutaite V
    J Neurochem; 2013 Sep; 126(5):604-15. PubMed ID: 23745639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism.
    Agrawal S; Abud EM; Snigdha S; Agrawal A
    Alzheimers Res Ther; 2018 Aug; 10(1):81. PubMed ID: 30115117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy-chain complementarity-determining regions determine conformation selectivity of anti-aβ antibodies.
    Sehlin D; Hedlund M; Lord A; Englund H; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
    Neurodegener Dis; 2011; 8(3):117-23. PubMed ID: 20714111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of IgG antibodies to beta-amyloid oligomers with surface plasmon resonance.
    Crisostomo AC; Dang L; Digambaranath JL; Klaver AC; Loeffler DA; Payne JJ; Smith LM; Yokom AL; Finke JM
    Anal Biochem; 2015 Jul; 481():43-54. PubMed ID: 25921794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.